Bausch + Lomb Corporation Logo

Bausch + Lomb Corporation (BLCO)

TSX

Currency in CAD
24.73
+0.38 (+1.56%)

Closed

Oct 7, 2026

Day's Range

24.56
24.77

52 wk Range

19.36
25.70

Overview - BLCO - Bausch + Lomb Corporation

Key Statistics

Valuation

Enterprise Value

18.94B

P/E (Trailing)

‪-23.52‬

P/E (Forward)

‪15.27‬

PEG Ratio

‪0.30‬

Price / Sales (TTM)

‪1.61‬

Price / Book

‪0.93‬

EV / EBITDA

‪16.40‬

Profitability

Gross Margin

‪62.19%‬

Profit Margin

‪-3.21%‬

Operating Margin

‪7.74%‬

Return on Assets

‪1.82%‬

Return on Equity

‪-2.51%‬

Ownership

Shares Outstanding

357.05M

Float

45.50M

Short % of Shares Outstanding

‪0.16%‬

Held by Insiders

‪87.29%‬

Held by Institutions

‪11.14%‬

Price stats

Beta

‪0.55‬

50-Day Avg

‪23.65‬

200-Day Avg

‪22.98‬

Dividends

Payout Ratio

‪0.00%‬

Analyst Consensus

Buy

13 analysts

News Teaser - BLCO - Bausch + Lomb Corporation

News & Analysis

View all news

Market Cap - BLCO - Bausch + Lomb Corporation

Peers - BLCO - Bausch + Lomb Corporation

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on TSX.

Profile Summary - BLCO - Bausch + Lomb Corporation

About

Bausch + Lomb Corporation is a global eye health company that develops, manufactures, and markets products for vision care, surgical care, and ophthalmic pharmaceuticals. Bausch + Lomb offers contact lenses, lens care solutions, eye drops, vitamins and supplements, and prescription therapies for a range of eye…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees13.50K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.